ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Luckily we spritzed and whiffed several new scents to find the seven best new florals, gourmands and even a second-skin scent ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

Explore a wide range of affordable, high-quality options, including some whiskey fans' longtime favorites. Each of these ...

A recent analysis based on samples collected in February has revealed a decline in the Yamuna's water quality, with the river ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...

Galilion Hotel and Kfar Giladi Hotel in the Upper Galilee are launching "The Wine Route," a unique vacation package that ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

Long-term high-intensity interval training may reduce the risk for the decline of kidney function in older adults, a study ...

I reviewed Epson's premium printer for photographers, the 17-inch wide-format SureColor P900, testing its quality, speed, usability, and value.

Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...